Texas Capital Bank Wealth Management Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,000	Closed	-$288K	–	201
2024 Q1	$288K	Buy	+5,000	New	+$290K	0.03%	162
2023 Q4	–	Sell	-5,000	Closed	-$240K	–	205
2023 Q3	$240K	Hold	5,000	–	–	0.03%	168
2023 Q2	$260K	Hold	5,000	–	–	0.03%	177
2023 Q1	$271K	Buy	+5,000	New	+$282K	0.03%	154

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

WWM

Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCWM

Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's BIB Position: Q2 2024 in Review

Texas Capital Bank Wealth Management Services sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2024, closing a stake of 5,000 shares — an estimated $288K sold.

Texas Capital Bank Wealth Management Services first reported a position in BIB in Q1 2023 and held it in 4 quarters. The position peaked at $288K in Q1 2024. 24 funds tracked by Wall St. Rank hold BIB as of Q2 2024.

Texas Capital Bank Wealth Management Services reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2024 after selling out during the quarter.
Texas Capital Bank Wealth Management Services sold 5,000 ProShares Ultra NASDAQ Biotechnology shares in Q2 2024, an estimated $288K.
Texas Capital Bank Wealth Management Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2023 and held it in 4 quarters.
Texas Capital Bank Wealth Management Services's ProShares Ultra NASDAQ Biotechnology position peaked at $288K in Q1 2024.
24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2024.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q2 2024, filed 15 Aug 2024.